PATENT CLAIM ANALYSIS

Application Number: 15922980
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "262100"]

Abstract:
To provide a novel compound having a HER2 inhibitory effect and having a cytostatic effect. It is also intended to provide a medicament useful in the prevention and/or treatment of a disease involving HER2, particularly, cancer, on the basis of the HER2 inhibitory effect. The present invention provides a compound of formula (I) wherein X, Y, Z 1 , Z 2 , Z 3 , Z 4 , W, n, R 1 , R 2 , and R 3  have meanings as defined in the present specification, or a salt thereof.

Claim (Index 23):
The method according to  claim 17 , wherein in the formula (I),\n X is a pyrrolidinyl group, a methylpyrrolidinyl group, a piperidinyl group, or a fluoro dinyl Y is and\n R 2  and R 3  are the same as or different from each other and each are a hydrogen atom, a methoxy group, a methyl group, or a phenyl group, or R 2  and R 3  optionally form, together with the nitrogen atom bonded thereto, an azetidinyl group optionally having a hydroxyl group as a substituent, a pyrrolidinyl group, or a piperidinyl group.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.76271
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15297196', '14784239', '14710631', '15861947', '12738885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7855404365003358
- 35 USC 102 Novelty (BERT): 0.5449890574949129
- Combined Prediction Score: 0.7614852985997935
- Mean Citation Score: 354.839194
- Max Citation Score: 379.9677
- Similarity Product: 282.87779236155154

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test